Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes

Journal of Clinical Investigation

Volumn 97, Issue 4, 1996, Pages 1010-1019

  Lenders, Jacques W M ^a   Eisenhofer, Graeme ^c   Abeling, Nico G G M ^b   Berger, Wolfgang ^a   Murphy, Dennis L ^d   Konings, C Henk ^f   Bleeker Wagemakers, Liesbeth M ^b   Kopin, Irwin J ^c   Karoum, Farouk ^e   Van Gennip, Albert H ^b   Brunner, Han G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e St Elizabeths Hospital   (United States)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

catecholamines; dihydroxyphenylglycol; metabolism; metanephrines; Norrie disease

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; PHENETHYLAMINE;

ADULT; ARTICLE; CASE REPORT; ENZYME DEFICIENCY; GENETIC ANALYSIS; HUMAN; MALE; MENTAL DEFICIENCY; NEUROCHEMISTRY; NORRIE DISEASE; PHENOTYPE; PRIORITY JOURNAL; SYNDROME; URINARY EXCRETION;

EID: 13344281037     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118492     Document Type: Article

References (49)

1. Youdim, M.B.H., J.P.M. Finberg, and K.F. Tipton. 1988. Monoamine oxidase. In Catecholamines I. Handbook of Experimental Pharmacology. U. Trendelenburg and N. Weiner, editors. Springer Verlag, New York. 119-192.
2. Weyler, W , Y.-P.P. Hsu, and X.O. Breakefield. 1990. Biochemistry and genetics of monoamine-oxidase. Pharmacol. & Ther. 47:391-417.
3. Berry, M.D., A.V. Juorio, and I.A. Paterson 1994. The functional role of monoamine oxidases A and B in the mammalian central nervous system. Progr. Neurobiol. (Oxf.). 42:375-391.
4. Kochersperger, L.M., E.L. Parker, M. Siciliano, G.J. Darlington, and R.M. Denney. 1986. Assignment of genes for human monoamine oxidases A and B to the X-chromosome J. Neurosci. 16:601-616.
5. Collins, F.A , D.L. Murphy, A.L. Reiss, K.B. Sims, J.G. Lewis, L. Freund, F. Karoum, D. Zhu, I.H. Maumencc, and S.E. Antonarakis 1992. Clinical, biochemical and neuropsychiatrie evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. Am. J. Med. Gener. 42:127-134.
6. Sims, K.B., A. de la Chapelle, R. Nono, E.-M. Sankila, Y.-P.P. Hsu, W.B. Rinehart, T J. Corey, L. Ozehus, J.F. Powell, G. Bruns, et al. 1989. Monoamine oxidase deficiency in males with an X chromosome deletion. Neuron. 2.1069-1076.
7. Bleeker-Wagemakers, E.M., I. Zweije-Hofman, and A. Gal. 1988. Norrie disease as part of a complex syndrome explained by a submicroscopic deletion of the X chromosome. Ophthalmic Paediatr Genet. 9:137-142.
8. Murphy, D.L , K.B. Sims, F. Karoum, A. de la Chapelle, R. Nono, E.-M. Sankila, and X.O. Breakefield. 1990. Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase J Neurochem. 54:242-247.
9. Donnai, D., R C Mountford, and A.P Read. 1988. Norrie disease resulting from a gene deletion, clinical features and DNA studies J. Med. Genet 25, 73-78.
10. Murphy, D.L., K.B. Sims, F. Karoum, N.A Garrick, A. de la Chapelle, E.M. Sankila, R. Nono, and X.O. Breakefield 1991. Plasma amine oxidase activities in Norne disease patients with an X-chromosomal deletion affecting monoamine oxidase. J. Neural Transm. 83:1-12.
11. Brunner, H.G , M.R. Nelen, P van Zandvoort, N.G.G.M. Abeling, A.H. van Gennip, E.C. Wolters, M.A. Kuiper, H.H. Ropers, and B A. van Oost. 1993. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 52:1032-1039.
12. Brunner, H.G., M. Nelen, X.O. Breakefield, H.H. Ropers, and B.A. van Oost. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A Science (Wash DC) 262-578-580.
13. Kopin, I.J. 1985. Catecholamine metabolism: basic aspects and clinical significance Pharmacol. Rev. 37:333-364.
14. Eisenhofer, G., and J.P.M. Finberg. 1994. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats. J Pharmacol. Exp. Ther. 268:1242-1251.
15. Eisenhofer, G., J.W M. Lenders, J Harvey-White, M. Ernst, A. Zametkin, D.L. Murphy, and I.J. Kopin. 1996 Differential inhibition of neuronal and extraneuronal monoamine oxidase. Neuropsychopharmacology. In press.
16. Eisenhofer, G., P. Friberg. K Pacak, D.S. Goldstein, D.L. Murphy. C. Tsigos, A.A. Quyyumi, H.G. Brunner, and J.W.M. Lenders. 1995. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin. Sci. (Lond.). 88 533-542
17. Berger, W., A. Meindl, T.J.R. van de Pol, F P.M. Cremers, H H. Ropers, C. Dòerner, A. Monaco, A.A.B. Bergen, R. Lebo, M. Warburg, et al. 1992. Isolation of a candidate gene for Norrie disease by positional cloning Nat. Genet 1:199-203.
18. Eisenhofer, G., B. Rundquist, A Åneman, P Friberg, N. Dakak, I.J Kopin, M.C. Jacobs, and J.W.M. Lenders. 1995. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J. Clin. Endocrinol. & Metab. 80:3009-3017.
19. Sunderland, T., E.A. Mueller, R.M. Cohen, D.C. Jimerson. D Pickar. and D.L. Murphy. 1985. Tyraminc pressor sensitivity changes during deprenyl treatment. Psychopharmacology. 86:432-437.
20. Miller, S.A , D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
21. Sims, K.B., R.V Lebo, G. Benso. C. Shalish, D Schuback, Z. Y. Chen, G. Bruns, I.W. Craig, M.S Golbus, and X.O. Breakefield. 1992. The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3. Hum. Mol. Genet. 1:83-89.
22. Grimsby, J., K. Chen, L.-J. Wang, N.C. Lan, and J.C. Shin. 1991 Human monoamine oxidase A and B genes exhibit identical exon-intron organization Proc. Natl. Acad. Sci. USA. 88:3637-3641.
23. Murphy, D.L., C. Wright, M. Buchsbaum, J. Costa, A. Nichols, and R Wyatt. 1976. Platelet and plasma amine activities in 650 normals: sex and age differences and stability over time. Biochem Med 16.254-265.
24. van Kempen, G M.J., J.L. van Brussel. and E.J.M. Penning. 1985. Assay of platelet monoamine oxidase in whole blood Clin. Chim. Acta 153:197-202.
25. Eisenhofer, G., D.S. Goldstein, R. Stull, H.R. Keiser, T. Sunderland. D L. Murphy, and I.J. Kopin. 1986. Simultaneous liquid chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase. Clin. Chem. 32:2030-2033.
26. Lenders, J.W.M , G Eisenhofer, I. Armando, H.R. Keiser, D.S Goldstein, and I.J. Kopin. 1993. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin. Chem 39:97-103.
27. Eisenhofer, G , W. Pecorella, K. Pacak, D. Hooper, I.J. Kopin. and D.S Goldstein 1994. The neuronal and extra-neuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats. J. Auton. Nerv. Syst. 50:93-107.
28. Karoum, F. 1983. Mass fragmentography in the analysis of biogenic amines: a clinical, physiological, and pharmacological evaluation. In Methods in biogenic amine research. S. Parvez, T. Nagatsu, I. Nagatsu, and H Parvez, editors. Elsevier, New York, 237-255.
29. Stroomer, A.E.M., H. Overmars, N.G.G.M Abeling, and A.H. Van Gennip. 1990. Simultaneous detection of acidic 3,4-dihydroxyphenylalanine metabolites and 5-hydroxy-indole-3-acetic acid in urine by high-performance liquid chromatography Clin. Chim. Acta. 36:1834-1837.
30. Abeling, N.G., A.H. van Gennip, H. Overmars, and P.A. Voûte. 1984. Simultaneous determination of catecholamines and metanephrines in urine by HPLC with fluorimetric detection. Clin. Chim. Acta. 137:211-226.
31. Karoum, F., H Nasrallah. S. Potkin, L. Chuang, J. Moyer-Schwing, I. Phillips, and R.J. Wyatt. 1979. Mass fragmentography of phenylethylamine, m- and p-tyramine, and related amines in plasma, cerebrospinal fluid, urine and brain J. Neurochem 33:201-202
32. Pickar, D., R.M. Cohen, D.C Jimerson, and D.L. Murphy. 1981. Tyramine infusions and selective monamine oxidase inhibitor treatment. I. Changes in pressor sensitivity. Psychopharmacology. 74:4-7
33. Murphy, D.L , F. Karoum, I Alterman, S. Lipper, and R.J. Wyatt. 1984. Phenylethylamine, tyramine and other trace amines in patients with affective disorders: associations with clinical state and antidepressant drug treatment. In Neurobiology of the trace amines A.A Boulton, G.B. Baker, W.G. Dewhurst. and M. Sandler, editors. Humana Press, Clifton, NJ. 449-514
34. Glover, V., M. Sandler, F. Owen, and G.J. Riley. 1977. Dopamine is a monoamine oxidase B substrate in man Nature (Lond.). 265:80-81.
35. Donnelly, C.H., and D.L. Murphy. 1977 Substrate- and inhibitorrelated characteristics of human platelet monoamine oxidase. Biochem Pharmacol. 26:853-858.
36. Eisenhofer, G., D.S. Goldstein, T.G. Ropchak, and I.J. Kopin. 1988. Source and physiological significance of plasma 3,4-dihydroxyphenylalamine in the rat. J. Neurochem. 51:1204-1213.
37. Buffoni, F. 1966. Histaminase and related amine oxidases. Pharmacol. Rev. 18:1163-1199.
38. McEwan, C.M. 1965. Human plasma monoamine oxidase. J. Biol. Chem. 240:2003-2010.
39. Campbell, I.C., D.S. Robinson, W. Lovenberg, and D.L. Murphy. 1979. The effects of chronic regimens of clorgyline and pargyline on monoamine oxidase metabolism in the rat brain. J. Neurochem. 32:49-55
40. Murphy, D.L., N A. Garrick, and R.M. Cohen. 1983. Monoamine oxidase inhibitors and monoamine oxidase. biochemical and physiological aspects relevant to human psycho-pharmacology. In Antidepressants G.D Burrows, T R. Norman, and B. Davies. editors. Elsevier, Amsterdam. 209-227.
41. Buchsbaum, M.S., R.D. Coursey, and D.L. Murphy. 1976. The biochemical high-risk paradigm: behavioral and familial correlates of low-platelet monamine oxidase activity. Science (Wash. DC). 194:339-341.
42. von Knorring, L., L. Oreland, and B. Winblad. 1984. Personality traits related to monoamine oxidase activity in platelets. Psychiatr. Res. 12:11-26.
43. Devor, E J., C.R Cloninger, P.L. Hoffman, and B Tabakoff. 1993. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. Am J. Med. Genet. 48:209-213.
44. Young, W.F., E. Laws, F.N. Sharbrough, and R.M. Weinshilbaum 1986. Human monoamine oxidase, lack of brain and platelet correlation. Arch Gen. Psychiatry. 43:604-609.
45. Chen, K., H.-F Wu, and J.C. Shih. 1993. The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical. J. Neurochem. 61:187-190
46. Paterson, I.A., A.V. Juorio, and AA Boulton. 1990. 2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system? J. Neurochem. 55:1827-1837.
47. Cases, O., I. Seif, J. Grimsby, P. Gaspar, K. Chen, S. Pournin, U. Müller, M. Aguet, C. Babinet, J C. Shih, and E De Maeyer. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO-A. Science (Wash. DC). 268:1763-1766.
48. Whitaker-Azmitia, P.M., X. Zhang, and C. Clarke. 1994. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology. 11:125-132.
49. Brunner, H.G. 1995. MAOA deficiency and abnormal behaviour: perspectives on an association In Genetics of Criminal and Antisocial Behaviour. M. Rutter, editor. Wily Liss, Chichester. UK. 155-167.